SCIENCE AND TECHNOLOGY - RELATED PUBLICATIONS OVERSIGHT HEARING ON THE ADMINISTRATION'S BUDGET PROPOSAL TO REPEAL SB 322 STEM CELL RESEARCH GUIDELINES - An oversight hearing held by the Senate Committee on Health & Human Services. Stem cell research has the potential to develop cures and better treatments for a variety of diseases as well as chronic conditions. They range from diabetes to Parkinson's, to spinal chord injury, to cancer and heart disease. The Governor's budget that he released in January proposes to repeal this legislation to require the Department of Health Services to develop guidelines for stem cell research that will be conducted in the State of California. (Stock #1260-S; $4.04 - includes tax s/h) (5/04) 2004 CALIFORNIA NANOTECHNOLOGY POLICY BRIEFING APPLICATIONS, IMPLICATIONS AND RECOMMENDATIONS - Transcript of the hearing by the Joint Committee on Preparing California for the 21st Century. Nanotechnology is the ability to work at the atomic and molecular levels (approximately 1/100,000th the diameter of the human hair). Nanotechnology involves the research and development of materials, devices and systems that exhibit physical, chemical and biological properties that are different from those found at larger scales. For more information on this subject visit the committee's website, http://www.senate.ca.gov/ftp/sen/committee/JOINT/CA21ST_CENTURY/_home/ (Stock #1258-S; $4.31 - includes tax s/h) (1/04) CALIFORNIA TANDEM MASS SPECTROMETRY PILOT PROGRAM RESULTS AND FOLLOW-UP - Hearing held by the Senate Select Committee on Genetics, Genetic Technology, and Public Policy. Each year, more than 500,000 babies are born in the State. The California Department of Health Services provides newborn genetic screening services. The basic service screens for four disorders: PKU, galactosemia, sickle cell disease, and hypothyroidism. Without early detection and treatment, these disorders can cause physical problems, mental retardation, and even death. In 2000, about 420 disorders were detected through the screening program. In January 2002, the department implemented the Tandem Mass Spectrometry Pilot Program to expand newborn screening from 4 to more than 30 disorders. The program ended in June 2003 due to the lack of funding. The enabling legislation by Senator Kuehl, AB 2427, required the department to submit a report to the legislature by January 2002, on the progress of the program. The report was to include "the costs for screening, follow-up, and treatment as compared to the costs of morbidity averted for each condition tested for in the program." The purpose of this hearing is to receive the program results, if available, and give interested parties an opportunity to discuss the program. The report is necessary before TMS will be integrated into the standard battery of newborn genetic testing techniques currently used in California. (Stock #1254-S; $5.12 - includes tax s/h) CALIFORNIA'S COMPULSORY STERILIZATION POLICIES, 1909 - 1979 (EUGENICIS) - This hearing is a follow up to a lecture that was hosted by the Senate Select Committee on Genetics, Genetic Technology & Public Policy. Dr. Paul Lombardo gave a lecture on the American Eugenics Movement (1217-S). At its prime during the early to mid 1900s, eugenics was practiced through immigration restriction laws, marriage restriction, selective breeding, and sterilization, among others. Because very few of the lawmakers, hospital superintendents, mental health directors, or others who were involved in the sterilization laws or practices are alive today, we're dependent upon researchers, historians, and archived records to help tell this story. We hope to learn from this history and be mindful of it as we consider mental health and genetics policies in the future. Dr. Alexandra Minna Stern, a renowned eugenics scholar, gives the presentation for this informational hearing held on July 16, 2003. (Stock #1242-S; $10.24 - includes tax s/h) (7/03) EUGENICS: LESSONS FROM A HISTORY HIDING IN PLAIN SIGHT - Hearing held by the Senate Select Committee on Genetics, Genetic Technologies and Public Safety on March 11, 2003 as part of a lecture series. The lecturer for this hearing is Paul A. Lombardo, Ph.D., J.D. These hearings or lectures are to heighten awareness of ethical, social, and legal issues involving cloning, newborn genetic screening programs, DNA databanking, genetic discrimination, and genetic testing. (Stock #1217-S; $3.23 - includes tax s/h) (3/03) TISSUE DONATIONS: ISSUES AND OPTIONS IN OVERSIGHT, REGULATION AND CONSENT - This report by the Senate Office of Research analyzes issues and options in regulation, licensing and fees, informed consent and other aspects of an industry that is saving and improving the quality of countless lives. The report also explores in detail the complicated issues surrounding for-profit activities and use of tissue for cosmetic purposes in a field driven by the altruism of bereaved families, who donate tissues from deceased loved ones with the goal of helping others. (Stock #1215-S; $3.23 - includes tax s/h) (4/03) RECENT HACKING OF STATE EMPLOYEE RECORDS AT THE TEALE DATA CENTER - Informational hearing by Senator Steve Peace and the Senate Privacy Committee. What went wrong at the Teale Data Center so that the personal information of over 200,000 state employees, including Senator Peace, as well as committee members, are now in the hands of hackers; and more importantly than what happened, why it happened; why did it take months to discover the hacking; why did it take another month before state employees were informed; what steps are being taken to prevent such circumstances from being repeated? (Stock #1175-S; $4.58 - includes tax s/h) (6/02) UTILIZING TECHNOLOGY IN THE CALIFORNIA DEPARTMENT OF CORRECTIONS - While California is the birthplace of the computer chip and home of Silicon Valley, state government's use of information technology has not kept pace with that legacy. The CDC is such a case. The largest department in state government, it still struggles with a pair of outmoded and mismatched information technology systems installed two and three decades ago. In this report the Senate Advisory Control in State Government concludes that CDC needs significant funding to construct an information technology system capable of meeting today's needs. (Stock #1167-S; $4.04 - includes tax s/h) (8/02) THE IMPACT OF FEDERAL POLICY ON REALIZING THE POTENTIAL OF STEM CELL RESEARCH (CHILDREN, DISEASE, DISABILITIES, HEALTH MEDICAL, SCIENCE, WOMEN) - This is the first in a series of hearings by the Health and Human Services Committee on stem cell research. The issues discussed are legislation and how we balance the appropriate relationship between the private and public sector; how we balance these very sensitive medical, ethical, and legal issues that we're facing in this policy area; and how do we ensure that stem cell research moves forward and that we pursue research in a responsible manner. (Stock #1152-S; $7.00 - includes tax s/h) (3/02) THE TRANSATLANTIC PARTNERSHIP AND THE SIGNIFICANCE OF THE EUROPEAN UNION TO CALIFORNIA AND ITS ECONOMY - Hearing held on March 6, 2002 by the Senate Committee's on Banking, Commerce & International Trade and California-European Trade Development. Some issues discussed were: The transatlantic partnership which has become even more important politically and strategically in the wake of the events of September 11th; The current European Union agenda, including the successful launch of the Euro as a legal tender currency, and its very positive implications for California business; and The vital and expanding relationship between the European Union and California. (Stock #1148-S; $4.85) (3/02) CALIFORNIA ADVISORY COMMITTEE ON HUMAN CLONING PRESENTS ITS RECOMMENDATIONS ON CLONING & STEM CELL RESEARCH - The purpose of this hearing held by the Senate Select Committee on Genetics, Genetic Technologies & Public Policy is to give the Advisory Committee an opportunity to present its findings and recommendations related to human cloning and stem cell research. Following their presentation and a question-and-answer period, there was an opportunity for public comments. (Stock #1149-S; $4.85 - includes tax s/h) (1/02) EXPANDED NEWBORN SCREENING POSSIBILITIES BY SUCHETTA BHATT, JAMES BARTLEY & GEORGE CUNNINGHAM - This hearing held on February 5, 2002 discusses the state's newborn genetic screening program, promising research, and what opportunities may exist for additional screenings and/or better detection of diseases such as PKU, sickle cell disease, and many others. (Stock #1146-S; $5.93 - include tax s/h) (2/02) STATE OF CALIFORNIA INFORMATIONAL TECHNOLOGIES POLICIES & PRACTICES (JOINT): SENATE BUDGET & FISCAL REVIEW #4, ASSEMBLY BUDGET #5, AND ASSEMBLY INFORMATION & TECHNOLOGIES - An informational hearing to discuss such issues as the state's annual expenditures for information technology, including equipment software and personnel; what is the current information technology policy, planning and procurement approval process; the evaluation of the state's success in using information technology. (Stock #1115-S; $4.31 - includes s/h) (8/01) OUTCOMES OR OUTRAGE: A GOLDEN OPPORTUNITY FOR CALIFORNIA. HOW IS CALIFORNIA MEASURING UP? This fourth report by the Senate Advisory Commission on cost control in State Government evaluates the current use of performance measurements in California State Government and reviews efforts of several states and private businesses and comments on Federal government efforts. The Commission believes that setting targets in costs, efficiency, services, program outcomes, and quality and them measuring the actual performance against these targets would result in significant improvement in every aspect of the State’s operations. It is clear that no business or government can operate successfully without a business plan with specific performance targets that become commitments resulting in complete accountability. At one time among states, California was regarded as the model for public administration. This is no longer the case. It is hoped that this report will encourage the Governor and the Legislature to restore the State of California to the eminent position it once held. (Stock #1078-S; $9.16 – includes tax s/h) (4/01) DEFENSE CONVERSION, RETENTION AND SPACE FLIGHT INDUSTRIES 1999 LEGISLATION SESSION SUMMARY – During the first half of the legislative session, the Select Committee held two hearings. They are the Joint Strike Fighter Hearing, 4/6/99 and the Hearing on California’s Aerospace Industry, 5/18/99. Also included in this report is the Delegation to the Pentagon, 5/5/99. (Stock #996-S; $6.73 – includes tax s/h) (9/99) “TRUTH AND CONSEQUENCES OF THE GENETIC REVOLUTION” -- A three-part series of informational hearings by the Senate Select Committee on Genetics and Public Policy to heighten awareness about the important issues of genetic research. Study areas include bioethics, public health, rights of privacy, assisted reproduction and preimplantation genetic diagnosis, discrimination, health care, DNA admissibility, accrediatation standards of genetic counselors, biotechnology and genetic education: Human Genetic Research, 4/8/96 (stock #893-S; $4.31 -- includes tax, s/h) (12/96) DNA on Trial, 5/9/96 (stock #894-S; $4.31 -- includes tax, s/h) (12/96) Animal Pharm: Old MacDonald Had a Lab, 6/24/96 (stock #895-S; $4.58 -- includes tax, s/h) (12/96)